Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue
Date:11/3/2010

o obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

(See attached tables.)ONYX PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share amounts)

(unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,2010200920102009Revenue: Revenue from collaboration agreement$
3,696$
9,137$   195,372$   183,074License revenue59,165-59,165-Total operating revenue122,86169,137254,537183,074Operating expenses:Research and development (1)44,56835,635131,39492,478Selling, general and administrative (1)25,92423,44077,29368,899Contingent consideration5,622-101,107-Total operating expenses76,11459,075309,794161,377Income (loss) from operations46,74710,062(55,257)21,697Investment income6281,0152,1983,108Interest expense (4,943)(2,255)(14,467)(2,255)Other expense(862)-(862)-Income (loss) before provision (benefit) for income taxes41,5708,822(68,388)22,550Provision (benefit) for income taxes70589(662)878Net income (loss)$
41,500$
8,233$   (67,726)$
21,672Net income (loss) per share:Basic$
.66$
.14$
(1.08)$
.37Diluted (2)$
.66$
.14$
(1.08)$
.37Computation of diluted shares:Basic 62,70760,24862,56258,201Dilutive effect of options142376-310Diluted (2)62,84960,62462,56258,511(1)  Includes employee stock-based compensation charges of:Research and development$
,075$
517$
3,090$
2,286Selling, general, and administrative4,7994,45513,50212,647Total employee stock-based compensation$
5,874$
4,972$
,592$
4,933(
2) Under the "if-converted" method, interest and issuance costs and potential common shares related to the Company's convertible senior notes were excluded in the computation of diluted per share amounts for the three and nine months ended September 30, 2010 and 2009 bec
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2010 Results
2. OncoMed Pharmaceuticals Awarded Five Therapeutic Discovery Project Grants Totaling $1.2 Million
3. Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010
4. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
5. ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
6. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
7. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
8. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
9. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
10. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
11. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 2015 With increasing clinical applications, the ... rise in active partnerships. The primary reason for ... quantitate CD4 cell markers in human immunodeficiency virus ... New analysis from Frost ... Market ( http://www.frost.com/nf0e ), finds the market earned ...
(Date:8/31/2015)... The Wolf Administration today announced 289 drug ... State Police and local police departments have ... Heroin and opioid overdose are the leading cause of ... more individuals than those involved in fatal motor vehicle ... drug overdose. " Pennsylvania ...
(Date:8/31/2015)... 31, 2015  The departments of Drug and Alcohol ... Gaudenzia Concept 90 to raise awareness for International Overdose ... Pennsylvania and help more Pennsylvanians ... recovery through the Building Bridges to Recovery ... every day to a disease that is fully treatable, ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2
... Although 2010 brought healthcare reform, investors are wondering ... likely expect some volatility in the sector, as the ... either through a repeal effort or withholding funding for ... & Poor,s Equity Research. "Healthcare reform ...
... BOTHELL, Wash., Jan. 13, 2011 SCOLR Pharma, Inc. (OTCQB: ... begin trading in the over-the counter (OTC) market beginning January ... is expected to be quoted on the OTC Bulletin Board ... cease trading on the NYSE Amex Exchange at the close ...
Cached Medicine Technology:S&P Equity Research Issues Health Care Sector Predictions for 2011 2S&P Equity Research Issues Health Care Sector Predictions for 2011 3S&P Equity Research Issues Health Care Sector Predictions for 2011 4S&P Equity Research Issues Health Care Sector Predictions for 2011 5S&P Equity Research Issues Health Care Sector Predictions for 2011 6SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011 2
(Date:9/1/2015)... Francisco, Calif. (PRWEB) , ... September 01, 2015 ... ... to corporations, law firms and government entities, announced today that it has hired ... Senior Discovery Consultant. In this capacity, Sanderson will be responsible for establishing ...
(Date:9/1/2015)... ... September 01, 2015 , ... Royal River Natural Foods, a locally-owned independent natural ... women for 19 years and found that, among those who had a stroke, people ... report is part of the September 2015 issue of “Natural Insights for Well Being,” ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... Brent Nelson, D.O., has joined its medical management team as an Associate Medical ... of all sizes and types in the U.S. and abroad. , Dr. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Two of Washington D.C.’s most ... through food and dining. , Recently named “the next big thing” in the ... known for telling the whole story behind food and reclaiming culinary traditions on the ...
(Date:9/1/2015)... ... 01, 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, ... of the Best” firm in the U.S., as well as being ranked a Top ... in the U.S., selected exclusively on performance in specific areas of financial and operational ...
Breaking Medicine News(10 mins):Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2
... infection with a reduced susceptibility to the potent antibiotic drug ... Ford Hospital study. Researchers found that patients who contracted ... hospital longer, were more likely to have the infection return ... from it after 90 days than patients who do not ...
... (Toronto) Mental illness is associated with more lost work ... $51 billion annually in lost productivity. In the first study ... Mental Health (CAMH) have calculated the actual cost of mental ... cost of a leave for a physical illness. ...
... A drug developed at the University of Kansas has ... often leads to pain in the extremities and even amputations, ... article showing that KU-32 can stop and even reverse diabetic ... death of nerves in the extremities of individuals with diabetes. ...
... Karen Pallarito HealthDay Reporter , THURSDAY, Sept. ... through large, employer-sponsored health plans will see a number ... paying more for that coverage, employers and benefits consultants ... and higher contributions from the individual members of the ...
... health decision-makers need to collaborate in a more efficient ... of supply shortages for pediatric vaccines but also to ... coverage, according to research published by a University of ... Sheldon H. Jacobson, a professor of computer science ...
... issue of the Hastings Center Report ... state to legalize physician-assistance in dying, either do not ... such assistance. Both legal and moral reasons are identified. ... important for assuring that physician-assisted death is carried out ...
Cached Medicine News:Health News:Henry Ford Hospital study: hVISA linked to high mortality 2Health News:Mental health leaves most costly disability to Canadian employers 2Health News:Drug holds promise to halt debilitating condition of diabetes 2Health News:Drug holds promise to halt debilitating condition of diabetes 3Health News:Health Care Reform: Employees Face Greater Cost-Sharing 2Health News:Health Care Reform: Employees Face Greater Cost-Sharing 3Health News:Health Care Reform: Employees Face Greater Cost-Sharing 4Health News:Pediatric vaccine stockpile policies need to be revisited, researcher says 2Health News:Pediatric vaccine stockpile policies need to be revisited, researcher says 3Health News:Study finds most Oregon hospices do not fully participate in the Death with Dignity Act 2
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
... The Volk G-1 trabeculum provides the highest ... Perfect for viewing and treating the trabecular meshwork. ... of the anterior chamber angle while the central ... view the posterior pole for signs of glaucoma ...
... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
... The 45° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
Medicine Products: